ACRES Commercial Realty (ACR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Reported GAAP net income allocable to common shares of $4.1 million, or $0.52 per diluted share, for Q4 2024, with a $7.5 million gain on a property sale boosting results.
Book value per share rose to $28.87, up from $27.92 in Q3 2024 and $26.65 in Q4 2023, reflecting a 14% annual increase since Q3 2020.
Management is focused on monetizing real estate investments, redeploying capital into the CRE loan portfolio, and targeting mid-teens ROEs and 8-10% EAD at book value.
Transitioning out of legacy real estate equity investments, with the process expected to largely complete in 2025.
94.6% of the $1.5 billion CRE loan portfolio is current on payments, with 77% multifamily exposure.
Financial highlights
GAAP net income allocable to common shares was $4.1 million ($0.52 per diluted share) for Q4 2024, including a $0.95 per share impact from a $7.5 million property sale.
EAD per diluted share was $0.48 for Q4 2024, up from $0.24 in Q3 but down from $0.55 in Q4 2023.
Book value per share increased to $28.87 at 12/31/24, up from $27.92 in Q3 2024 and $26.65 in Q4 2023.
Net interest income was $8.6 million; net CRE loan repayments totaled $81.8 million in Q4 2024.
$176.6 million invested in real estate and properties held for sale.
Outlook and guidance
Portfolio expected to grow to $1.8–$2.0 billion by year-end 2025, up from $1.5 billion.
EAD profile anticipated to trend upward after a low point in early 2025 as capital is redeployed and leverage increases.
Management remains focused on EAD growth, share repurchases, and expanding the loan portfolio in high-growth markets with experienced sponsors.
Monetization of remaining real estate investments expected to be largely completed in 2025.
Latest events from ACRES Commercial Realty
- $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.ACR
Proxy Filing1 Dec 2025 - Q2 2025 saw a net loss, $27.93 book value per share, and a $1.4B CRE loan portfolio.ACR
Q2 202516 Nov 2025 - Q3 net income was $9.8M ($1.34/share), book value rose, and portfolio growth is expected.ACR
Q3 20256 Nov 2025